Source: Health Canada shortage reports · Updated Jul 20, 2026
Some Diclofenac products are in shortage in Canada (2 of 7 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jul 31, 2026.
A nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain and inflammation.
Products affected
2 / 7
In shortage since
Nov 11, 2019
Est. full return
Jul 31, 2026
Reports on file
21
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
SANDOZ DICLOFENAC RAPIDE
50MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02261774 · since May 11, 2026, est. end Jul 31, 2026 · Demand increase for the drug.
Active shortage
APO-DICLO RAPIDE 50 MG TABLETS
50MG · TABLET · APOTEX INC
DIN 02243433 · since Nov 11, 2019, no end estimate · Disruption of the manufacture of the drug.
DIN 00881635 · ended Dec 19, 2024 · Demand increase for the drug.
Resolved
SANDOZ DICLOFENAC RAPIDE
50MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02261774 · ended Dec 2, 2024 · Disruption of the manufacture of the drug.
Resolved
DICLOFENAC K
50MG · TABLET · SANIS HEALTH INC
DIN 02351684 · ended Mar 1, 2024 · Disruption of the manufacture of the drug.
Resolved
SANDOZ DICLOFENAC RAPIDE
50MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02261774 · ended Jan 18, 2023 · Delay in shipping of the drug.
Resolved
SANDOZ DICLOFENAC RAPIDE
50MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02261774 · ended Oct 19, 2022 · Requirements related to complying with good manufacturing practices.
Discontinued
PMS-DICLOFENAC K
50MG · TABLET · PHARMASCIENCE INC
DIN 02239753
Resolved
SANDOZ DICLOFENAC RAPIDE
50MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02261774 · ended Mar 5, 2021 · Demand increase for the drug.
Resolved
SANDOZ DICLOFENAC RAPIDE
50MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02261774 · ended Oct 23, 2020 · Competitive BO
Showing 12 of 21 reports. All reports are on file with Health Canada.
What's happening
Diclofenac is currently affected by 2 active shortage reports filed with Health Canada by SANDOZ CANADA INCORPORATED, APOTEX INC.
The reported causes are: demand increase for the drug; disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Diclofenac is classified under “ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS” (ATC M01AB).
Recent changes
Jul 20, 2026
Estimated end date pushed back : Jul 24, 2026 → Jul 31, 2026
Common questions
What is Diclofenac used for?
A nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain and inflammation.
When will Diclofenac be back in stock in Canada?
The latest manufacturer estimate is Jul 31, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Diclofenac in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.